TransMedics officer files initial Form 3 report

TransMedics Group, Inc. officer Matthew S. Forsyth filed an initial Form 3 insider ownership report.

Rhea-AI Filing Summary

TransMedics Group, Inc. officer Matthew S. Forsyth filed an initial Form 3 insider ownership report. This filing establishes him as a reporting officer of the company. The data provided shows no reported purchases, sales, option exercises, gifts, or other insider transactions at this time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the TransMedics (TMDX) Form 3 filing for Matthew S. Forsyth show?

The Form 3 filing shows that Matthew S. Forsyth is an officer of TransMedics Group, Inc. It serves as his initial insider ownership report, with no purchases, sales, option exercises, or other insider transactions reported in the provided data.

Did Matthew S. Forsyth buy or sell TransMedics (TMDX) shares in this Form 3?

No insider trading activity appears in this Form 3 data. All transaction counts, including buys, sells, exercises, gifts, tax withholdings, and restructurings, are listed as zero, indicating no reported trades associated with this initial ownership filing.

Why is Matthew S. Forsyth considered an insider at TransMedics (TMDX)?

He is classified as an officer of TransMedics Group, Inc., which makes him a reporting insider under SEC rules. Officers, directors, and certain large shareholders must file Forms 3, 4, and 5 to disclose their holdings and any changes in their positions.

What is the purpose of a Form 3 for TransMedics (TMDX) insiders?

Form 3 is the initial statement of beneficial ownership for new insiders at a public company. It formally records their status as reporting persons and provides a baseline for future Forms 4 and 5, which will show any subsequent changes in their holdings.

Does this TransMedics (TMDX) Form 3 include any derivative securities activity?

No derivative activity is shown in the provided data. The derivative transaction count and exerciseShares are both zero, and the derivativeSummary section is empty, indicating no options, warrants, or other derivative transactions were reported in this filing excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/13/2026 - 05:30 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Forsyth Matthew S.

(Last) (First) (Middle)

C/O TRANSMEDICS GROUP, INC.

200 MINUTEMAN ROAD

(Street)

ANDOVER MA 01810

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/09/2026

3. Issuer Name and Ticker or Trading Symbol
TransMedics Group, Inc. [ TMDX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List Exhibit 24 - Limited Power of Attorney Senior Vice President, General Counsel and Secretary

No securities are beneficially owned.

	By: /s/ Gerardo Hernandez, Attorney-in-Fact	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.